DOCSLIB.ORG

5 EVENTS in ONE: Head Real World Evidence and Big Data Solutions Novartis, Switzerland

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
5 EVENTS in ONE: Head Real World Evidence and Big Data Solutions Novartis, Switzerland FIFTH ANNUAL - LIFE SCIENCE R&D DATA INTELLIGENCE LEADERS FORUM Basel, Switzerland January 23-24th, 2018 Optional Workshop 22nd, January Hear keynote presentations from the experts: Etzard Stolte Global Head Knowledge Management Roche, Switzerland Abhimanyu Verma 5 EVENTS IN ONE: Head Real World Evidence and Big Data Solutions Novartis, Switzerland Day 1: Torsten Niederdraenk Head of Technology Center Strategic Developments in R&D Big Siemens Healthcare, Germany Data Catherine Brownstein Scientific Director Day 2 (am): Stream 1 Manton Center for Orphan Disease Research Boston Children’s Hospital, USA Discovery & Omics Data Excellence Navin Ramachandran Radiology Consultant Day 2 (am): Stream 2 University College London Hospitals NHS Foundation Trust, Healthcare specialist in distributed ledgers and IoT Clinical & Patient Level Data IOTA Foundation, UK Excellence Marie-Claire Peakman Executive Director, Head Hit Discovery & Lead Profiling, Medicine Design Day 2 (pm): Stream A Pfizer, USA R&D IT & Bioinformatics Alex Zhavoronkov Co-founder, Insilico Medicine, CSO Day 2 (pm): Stream B The Biogerontology Research Foundation, UK Ivana Schnur Digital Health Collaborations Co-founder, CMO Sense.ly, USA Pre-Event Workshop: Jan 22nd Paul Wicks Artificial Intelligence for Drug Vice President of Innovation PatientsLikeMe, UK Discovery: Workshop for Senior Jazz Panchoo Global Strategy Head, VP, Digital Platforms Executives Ascensia Diabetes Care, Switzerland This Event is Certified for Continuing Professional Development with more than 30 presentations from R&D Data Experts Speakers Overview: Expert Speakers: Life Sciences Industry Independent Thought Leaders Academic Research Institutes Etzard Stolte Istvan Enyedy Brian Kennedy Catherine Brownstein Global Head Knowledge Senior Scientist, Professor of Biochemistry and Scientific Director Management Computational Chemistry Director Centre for Healthy Manton Center for Orphan Roche, Switzerland Biogen, USA Ageing, Yong Loo Lin School of Disease Research Medicine, National University Boston Children’s Hospital, USA Abhimanyu Verma Francis Kendall Singapore Head Real World Evidence and Digital Strategy Leader Emanuele de Rinaldis Big Data Solutions Roche, USA Andrew Beal Head of Translational Novartis, Switzerland Director, Blockchain and Bioinformatics Hans Martens Distributed Infrastructure King’s College London - NIHR Panos Papakonstantinou Regional Privacy Manager Ernst & Young, USA Biomedical Research Centre, UK Head of Digital Commercial, Europe Europe GSK, Netherlands Navin Ramachandran Sven Nahnsen Novartis, Switzerland Radiology Consultant Head of the Quantitative Adam Yeung University College London Biology Center Torsten Niederdraenk Strategy & Business Hospitals NHS Foundation Trust, University Tübingen, Germany Head of Technology Center, Development Manager, Healthcare specialist in distributed Germany Bruno Silva Siemens Healthcare, Europe & EMA ledgers and IoT Switzerland Head of Design and Product BD, IOTA Foundation, UK Michael Rebhan Development Senior Investigator Global Strategy Jazz Panchoo, Isabelle Hilali Arnhold Institute for Global Novartis Institutes for Head, VP, Digital Platforms Managing Director Health, USA BioMedical Research, Ascensia Diabetes Care, Center for Research and Switzerland Switzerland Ian McNicoll Interdisciplinarity (CRI), and Co-chair Board member, Healthcare Data Edgar Jacoby Chris Shilling openEHR Foundation, UK Senior Principal Scientist Consultant, Innovation Vizier, Institute (HDI), France Molecular Informatics UK Pharma Diagnostics, David Wortley, President of Janssen, Belgium Marie-Claire Peakman European Chapter, International Alex Zhavoronkov Executive Director, Head Hit Society of Digital Medicine Co-founder, Insilico Medicine, Discovery & Lead Profiling, (ISDM), Founder, GAETSS, UK CSO, The Biogerontology Medicine Design Research Foundation, UK Pfizer, USA R&D HW/SW Developers Patient Platforms Sebastian Streit Zhenyu Xu Jon McLoone Paul Wicks Team Lead Global Solution Chief Technology Officer Director of Technical Vice President of Innovation, Center - Automation Sophia Genetics, Switzerland Communication and Strategy, PatientsLikeMe, UK Integration & Artworks Wolfram Research, UK Roche, Switzerland Stephen A. Brobst Ivana Schnur CTO Co-founder, CMO Teradata Corporation Sense.ly, USA Peter Grolimund Yury Rozenman, Director Sr. Life Science Industry Consultant, of Business Development, ThinkBig Analytics (a Teradata Qualcomm Life, USA company) Event Partners: Event Structure PRE-EVENT WORKSHOP DAY 1 DAY 2 (24th January) (am) DAY 2 (24th January) (pm) (22nd January) (23rd January) STREAM 1: STREAM A: DISCOVERY & OMICS R&D IT & DATA EXCELLENCE BIOINFORMATICS ARTIFICIAL STRATEGIC INTELLIGENCE FOR DEVELOPMENTS DRUG DISCOVERY: IN R&D BIG DATA WORKSHOP FOR STREAM 2: STREAM B: SENIOR EXECUTIVES CLINICAL & DIGITAL HEALTH PATIENT-LEVEL DATA COLLABORATIONS EXCELLENCE Who Will Benefit: Scientific Officers, Chief Information Officers, Chief Technology Officers, Knowledge & Data Management (Discovery, Clinical & Real-World Data), R&D Analytics, Informatics, R&D Innovation, External Alliances & Innovation, R&D Strategy. Also: VPs Directors & Senior Managers involved in: Stream 1: Drug Discovery, R&D, Lead Identification & Target Validation, Screening, Translational R&D, Genomics & Proteomics, Biomarker R&D, Senior Scientist, Biostatistics, Biometrics, Precision Medicine, Personalised Medicine, Computational Biology. Stream 2: Clinical Development, Clinical Data Management, e-Clinical, Electronic Data Management, Health Economics & Outcomes Research, Real-World Evidence Generation, Late-Phase Research, Epidemiology, Drug safety & Pharmacovigilance, Medical Information. Stream A: Information Technology & Services, R&D IT, IT Hardware & Infrastructure, Software, Database Management. Stream B: eHealth, mHealth, Connected Health, Digital Health Solutions, Strategic Medical Innovation, Business Development, Strategic Collaborations, Alliances, External Innovation, Patient Engagement Event Overview Achieving excellence with R&D data will enable the life sciences industry to increase the speed and quality of innovation and is thus a major source of competitive advantage. Whether researchers and informaticians deal with “big data,” “deep data” or just put their data to smarter use, it is clear that the future of R&D is dependent on both smart technologies and clever researchers. The rapid progress of innovation in software and powerful hardware now allows human researchers to interpret masses of amounts of raw data in unique ways and is redefining the R&D business model. The benefits range from discovery and “omics” research, through to clinical trials and to real patients in the real-world. However, it is major technical, financial and operational challenge to turn “messy” data into structured data, that can be used for advanced analytics that can spot opportunities and achieve true insights. Some of the most promising areas of technological innovation making rapid progress include, for example, artificial intelligence, machine learning, cloud computing and the blockchain (distributed ledgers). There is also huge potential for efficient collaborations between the life science industry, technology companies, academic researchers, health systems, physicians and health insurers. A deeper convergence between key stakeholders and advanced technologies will facilitate the discovery and development of powerful therapies, devices and advanced diagnostics to benefit patients. The “R&D Data Intelligence Leaders Forum” is the must attend event for those senior decision-makers, researchers and technologists, looking to make the shift towards an integrated R&D and data strategy and for those looking to improve their implementation of data- driven approaches to enhance R&D decision-making and intelligence. Day One – Strategic Developments in R&D Big Data Will feature several keynote presentations from thought leaders from both the R&D and technology perspectives on how data is redefining the R&D model and enabling R&D decision making and innovation. This strategic-level discussion from senior-level experts will look at what technologies and approaches are already creating an impact in R&D, but also what will be critical tomorrow. They will discuss what technological, financial, regulatory and operational challenges need to be overcome to ensure that key insights are achieved and R&D intelligence is dramatically enhanced to ensure patient benefit. Day 2 (am) - Stream 1: Discovery & Omics Data Excellence This stream will focus on how to plan and implement data driven approaches in the drug discovery process to unlock innovation. Huge volumes of raw data can be merged with other data sets, structured and analysed from a myriad of perspectives, to not just achieve answers to complex research questions, but to also develop new hypotheses themselves. Attendees will understand how a dedicated R&D data strategy for precision medicines and large “Omics” data volumes can achieve deep insights that enhance R&D decision making and innovation. Day 2 (am) - Stream 2: Clinical & Patient-Level Data Excellence This stream will feature best practice case studies of designing, collecting & managing large sets of clinical-stage and patient-level data from both clinical and informatics experts. Specific attention will be paid to taking advantage of electronic data capture (EDC) technologies, but also the potential of new techs such as the blockchain. This stream will also feature examples
Load more

Recommended publications
  • Fundamentals and Implementation of the Openehr Standard the Open Standard for Future Proof Health Information Systems
    Fundamentals and Implementation of the openEHR standard the open standard for future proof health information systems Course objectives The main goal of this course is for students to get to know the openEHR specifications, it's role and purpose on health informatics projects, it's scope and how it can work together with other standards. Including how openEHR contributes to improve health information systems quality, and how it enables interoperability. Students will be instructed in the openEHR Information Model Specifications, in the Archetype Model and Archetype Definition Language (ADL) Specifications, and in Software Tools for modeling and sharing Archetypes and Templates. All these topics will be linked together with general concepts of clinical record structure, information model architectures and interoperability. Why do we need this course? Health information system projects are booming. Some projects had some level of success and are now very lucrative products, but most didn't have the expected impact or even failed after huge investments. This is due multiple factors, including deficient or incomplete technical proposals that do not contemplate or limit the action of the health professional, lack of standardization of health information that limits the ability to share and reuse information, a huge technological dependency created by the software industry, in-house developments or acquisitions of canned systems that are not capable of being adapted to specific needs and evolve with changing requirements of clinical information is a sustainable way. The openEHR standard proposes solutions for some of these problems and challenges, with a completely new paradigm of designing health information systems, that empowers the health care professional making them fundamental actors in developing new health information systems, in a vendor-neutral way.
    [Show full text]
  • Implementation of Openehr in Combination with Clinical Terminologies: Experiences from Norway
    International Journal on Advances in Life Sciences, vol 9 no 3 & 4, year 2017, http://www.iariajournals.org/life_sciences/ 82 Implementation of OpenEHR in Combination with Clinical Terminologies: Experiences from Norway Rune Pedersen Conceição Granja, Luis Marco Ruiz Norwegian Centre for eHealth Research Norwegian Centre for eHealth Research University Hospital of North Norway University Hospital of North Norway Telemedicine- and eHealth Tromsø, Norway University of Tromsø {conceicao.granja, luis.marco.ruiz}@ehealthresearch.no [email protected] Abstract—Norway is currently involved in several initiatives to operation needs not only efficient technologies but also the adopt clinical information standards and terminologies. This ability of these technologies to exchange information without paper aims to identify and discuss challenges and experiences any ambiguity or loss of meaning, i.e., interoperate at a se- for large-scale national implementation projects when working mantic level [10]. towards structured Electronic Health Records systems, process Enabling semantic interoperability (SIOp) across and decision support, and secondary use of clinical data. This healthcare technological platforms is needed in order to guar- paper reports from the national strategy for OpenEHR adop- antee that different stakeholders will derive the same conclu- tion in Northern Norway Regional Health Authority encour- sions from the same data set [10]. If SIOp is not granted across aged by the development of a national repository for OpenEHR organizational boundaries, the lack of precision in specifying archetypes and a national initiative to integrate clinical termi- the meaning of the information shared may lead to misinter- nologies. The paper contributes to a qualitative longitudinal in- terpretive study with an effort to increase the possibility to ob- pretations of healthcare data jeopardizing the quality of care tain semantic interoperability (towards integrated care) and dis- and hampering research outcomes.
    [Show full text]
  • Implement an International Interoperable PHR by FHIR—A Taiwan Innovative Application
    sustainability Article Implement an International Interoperable PHR by FHIR—A Taiwan Innovative Application Yen-Liang Lee 1,2, Hsiu-An Lee 3,4,5,*, Chien-Yeh Hsu 4,5,6,*, Hsin-Hua Kung 4,5 and Hung-Wen Chiu 1,* 1 Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei 110, Taiwan; [email protected] 2 Internet of Things Laboratory, Chunghwa Telecom Laboratories, TaoYuan 326402, Taiwan 3 Department of Computer Science and Information Engineering, Tamkang University, New Taipei 251301, Taiwan 4 Standards and Interoperability Lab, Smart Healthcare Center of Excellence, Taipei 112303, Taiwan; [email protected] 5 Department of Information Management, National Taipei University of Nursing and Health Sciences, Taipei 112303, Taiwan 6 Master Program in Global Health and Development, Taipei Medical University, Taipei 110, Taiwan * Correspondence: [email protected] (H.-A.L.); [email protected] (C.-Y.H.); [email protected] (H.-W.C.) Abstract: Personal health records (PHRs) have lots of benefits for things such as health surveil- lance, epidemiological surveillance, self-control, links to various services, public health and health management, and international surveillance. The implementation of an international standard for interoperability is essential to accessing personal health records. In Taiwan, the nationwide exchange platform for electronic medical records (EMRs) has been in use for many years. The Health Level Seven International (HL7) Clinical Document Architecture (CDA) was used as the standard of the EMRs. However, the complication of implementing CDA became a barrier for many hospitals to real- ize the standard EMRs. In this study, we implemented a Fast Healthcare Interoperability Resources (FHIR)-based PHR transformation process including a user interface module to review the contents of PHRs.
    [Show full text]
  • SENS-Research-Foundation-2019
    by the year 2050, cardiovascular an estimated 25-30 the american 85 percent of adults disease years and older age 85 or older remains the most population will suffer from common cause of 2 1 2 dementia. death in older adults. triple. THE CLOCK IS TICKING. By 2030, annual direct The estimated cost of medical costs associated dementia worldwide was 62% of Americans with cardiovascular $818 billion diseases in the united over age 65 have in 2015 and is states are expected to more than one expected to grow to rise to more than chronic condition.1 3 $2 trillion $818 billion. by 2030.1 References: (1) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732407/, (2) https://www.who.int/ageing/publications/global_health.pdf, (3) https://www.cdcfoundation.org/pr/2015/heart-disease-and-stroke-cost-america-nearly-1-billion-day-medical-costs-lost-productivity sens research foundation board of directors Barbara Logan Kevin Perrott Bill Liao Chairperson Treasurer Secretary Michael Boocher Kevin Dewalt James O’Neill Jonathan Cain Michael Kope Frank Schuler 02 CONTENTS 2019 Annual Report 04 Letter From The CEO 06 Outreach & Fundraising 08 Finances 09 Donors erin ashford photography 14 Education 26 Investments 20 Conferences & Events 30 Research Advisory Board 23 Speaking Engagements 31 10 Years Of Research 24 Alliance 32 MitoSENS 34 LysoSENS 35 Extramural Research 38 Publications 39 Ways to Donate cover Photo (c) Mikhail Leonov - stock.adobe.com special 10th anniversary edition 03 FROM THE CEO It’s early 2009, and it’s very late at night. Aubrey, Jeff, Sarah, Kevin, and Mike are sitting around a large table covered in papers and half-empty food containers.
    [Show full text]
  • The Strategy for Telemedicine in Lublin Province
    JOURNAL OF MEDICAL INFORMATICS & TECHNOLOGIES Vol. 15/2010, ISSN 1642-6037 telemedicine, remote consultations, health records standardisation Rafal STEGIERSKI 1, Pawel MIKOLAJCZAK 1, Karol KUCZYNSKI 1, Waldemar SUSZYNSKI 1, Maciej SICZEK 2 THE STRATEGY FOR TELEMEDICINE IN LUBLIN PROVINCE Main role of this article is presentation, in a very short way, most important results of over two years of work board of experts from two universities, two clinical hospitals, city hall and also medical software and hardware suppliers. As a main purpose of strategy improvement of health care level in region was set. This aim will be achieved by telemedical infrastructure development, creation and implementation of procedures and instant training of staff. Strategy is focused on three main aspects. First one groups medical projects, second infrastructure project and third one is regional centre of coordination. In medical area proposed changes are mainly focused on telemedical support for emergency services, remote medical consultations and complex home monitoring of patients. Main solution for infrastructure assumes creation of integrated information system for hospitals and emergency units. I this part of the strategy selection of the proper standards for data storing and exchange. Probably one of the best choices is OpenEHR. Last part is centre of cooperation which consists of coordination centre of telemedical services, telemedical projects management unit, and training facility. 1. INTRODUCTION Lublin Telemedical network has a chance to be a modern system of cooperation of patients, medical staff and administration departments of hospitals and medical centres which could break as geographical as social limits in access to modern medical services. This state could be obtained via simplification of medical information flow and standardisation of data storage and exchange in medical information systems.
    [Show full text]
  • Read Our New Annual Report
    The seeds of a concept. The roots of an idea. The potential of a world free of age-related disease. Photo: Sherry Loeser Photography SENS Research Foundation Board of Directors Barbara Logan, Chair Bill Liao, Secretary Kevin Perrott, Treasurer Michael Boocher Jonathan Cain Kevin Dewalt Michael Kope Jim O’Neill Frank Schüler Sherry Loeser Photography 2 Contents CEO Letter (Jim O’Neill) 4 Finances 5 Donors 6 - 7 Fundraising & Conferences 8 - 9 Around the World with Aubrey de Grey 10 Outreach 11 Founding CEO Tribute & Underdog Pharmaceuticals 12 - 13 Investments 14 Welcome New Team Members 15 Education 16 - 17 Publications & Research Advisory Board 18 Research Summaries 19 - 22 Ways to Donate 23 The SRF Team Front row: Anne Corwin (Engineer/Editor), Amutha Boominathan (MitoSENS Group Lead), Alexandra Stolzing (VP of Research), Aubrey de Grey (Chief Science Officer), Jim O’Neill (CEO), Bhavna Dixit (Research Associate). Center row: Caitlin Lewis (Research Associate), Lisa Fabiny-Kiser (VP of Operations), Gary Abramson (Graphics), Maria Entraigues-Abramson (Global Outreach Coordinator), Jessica Lubke (Administrative Assistant). Back row: Tesfahun Dessale Admasu (Research Fellow), Amit Sharma (ImmunoSENS Group Lead), Michael Rae (Science Writer), Kelly Protzman (Executive Assistant). Not Pictured: Greg Chin (Director, SRF Education), Ben Zealley (Website/Research Assistant/ Deputy Editor) Photo: Sherry Loeser Photography, 2019 3 From the CEO At our 2013 conference at Queens College, Cambridge, I closed my talk by saying, “We should not rest until we make aging an absurdity.” We are now in a very different place. After a lot of patient explanation, publication of scientific results, conferences, and time, our community persuaded enough scientists of the feasibility of the damage repair approach to move SENS and SENS Research Foundation from the fringes of scientific respectability to the vanguard of a mainstream community of scientists developing medical therapies to tackle human aging.
    [Show full text]
  • A New Wave in Health Informatics : a Brief Overview
    International Journal of Pure and Applied Mathematics Volume 118 No. 18 2018, 4555-4560 ISSN: 1311-8080 (printed version); ISSN: 1314-3395 (on-line version) url: http://www.ijpam.eu Special Issue ijpam.eu A New Wave In Health Informatics : A Brief Overview 1M J Yogesh And 2J Karthikeyan 1Research Scholar, School of Information Technology,VIT University,Vellore E-mail: [email protected] 2School of Information Technology,VIT University, Vellore E-mail: [email protected] ABSTRACT The term Health Informatics has become a famous word in recent years because of its increasing usage day by day which has opened up many opportunities in healthcare industries and the medical field at large. Nowadays all kinds of data are being analysed for insights. In this paper, we discuss a brief overview of health informatics and usage of Electronic Health Records (EHRs) and research ideas to get meaningful information from medical data. A new wave has begun to make use of health informatics in providing quality treatment and the required help for doctors which makes their and patient's lives much more meaningful. Keywords—Health informatics; Neuro-informatics; Clinical informatics; EHRs 1.INTRODUCTION The basic goal of Health Informatics is to take in real world medical data (tissue, molecule, patient, population) to help advance our understanding of medicine and medical practice. Health Informatics is a combination of information science and computer science within the realm of healthcare. “There are numerous current areas of research within the field of Health Informatics, including Image Informatics (e.g. Neu- roinformatics), Clinical Informatics, Public Health Informatics, and also Translational BioInformatics (TBI).
    [Show full text]
  • Introducing Openehr
    Introducing openEHR © 2003-2007 The openEHR Foundation The openEHR Foundation is an independent, non-profit community, facilitating the sharing of health records by consumers and clinicians via open-source, standards-based implementations. Founding David Ingram, Professor of Health Informatics, Chairman CHIME, University College London Founding Dr P Schloeffel, Dr S Heard, Dr D Kalra, D Lloyd, T Beale Members email: [email protected] web: http://www.openEHR.org Overview of openEHR Introducing openEHR Rev 1.1 Overview of openEHR The Foundation The openEHR Foundation is a not-for-profit company, limited by guarantee. Its founding sharehold- ers are University College London, UK and Ocean Informatics Pty Ltd, Australia. It is regulated under the UK Companies Acts 1985 and 1989. The aims and management of the Foundation, exer- cised through its Board of Directors, are described on the openEHR website. The Board is responsi- ble for the governance of the Foundation, including strategic direction, financial management, legal regulation, and intellectual property (IP) management. The Board determines the roles, structures, and procedures of the Foundation and ensures that these function correctly. The major work of techni- cal and clinical oversight and supervision of openEHR product developments is delegated to the Architectural Review Board (ARB) and Clinical Review Board (CRB). Aims The openEHR Foundation is dedicated to the development of an open, interoperable health comput- ing platform, of which a major component is clinically effective and interoperable electronic health care records (EHRs). It does this by researching clinical requirements, and creating specifications and implementations. The specifications take the form of modular information models, service models and clinical information models.
    [Show full text]
  • Enabling Agents to Retrieve Openehr- Based Health Data Through Implementing HL7 Communication with Departmental Information Systems
    5th ed Enabling agents to retrieve openEHR- based health data through implementing HL7 communication with departmental information systems Paulo Roberto da Silva Ferreira OCT|2012 5th ed Enabling agents to retrieve openEHR- based health data through implementing HL7 communication with departmental information systems Paulo Roberto da Silva Ferreira Ricardo João Cruz Correia Pedro Manuel Vieira Marques OCT|2012 “Standardized access to knowledge systems and bibliographic systems must support scripting and data-entry mechanisms to ensure that a data system can properly and accurately provide a response.” “User queries will need to identify the patient and either request or transmit data elements to other components of the distribution environment.” “Vendors may interpret the use of a data field differently, depending on their perspective or orientation.” W. E. Hammond and J. J. Cimino in (Garber, et al., 2006) Acknowledgements To my thesis advisor and friend Prof. Dr. Ricardo Cruz Correia, for his guidance during the development of this work, especially his scientific input was very helpful to me in my long learning in these past years. Thank you to believing in my capabilities and mainly to empower them. To Dr. Pedro Manuel Vieira Marques, whose dedication, motivation and perseverance were essential to the achievement of this work. To the Prof. Dr. Luis Filipe Coelho Antunes, for his always innovative vision as director of the Master in Medical Informatics. To my master colegues Bruno Santos, Alexandre Santos, Carlos Vicente, Liliana Leite and Fernando Almeida. To the CIDES, Faculty of Medicine, University of Porto, the Centre for Research in Information Systems and Technologies Health (CINTESIS) and project PTDC/EIA-EIA/105352/2008 "SAHIB - Enhancing multi- institutional health data availability through multi-agent Systems", funded by the Foundation for Science and Technology, for providing the means and resources needed for this work.
    [Show full text]
  • How to Think and Act Rationally
    1 How to Be Rational: How to Think and Act Rationally David Robert [email protected] Abstract: This paper is divided into 4 sections. In Sections 1 and 2, I address (1) how to acquire rational belief attitudes and (2) how to make rational choices. Building on Sections 1 and 2, I then answer two of the most pressing questions of our time: (3) Should you be skeptical of climate change? (4) Should you invest in life-extension medical research? It has always appalled me that really bright scientists almost all work in the most competitive fields, the ones in which they are making the least difference. In other words, if they were hit by a truck, the same discovery would be made by somebody else about 10 minutes later. —Aubrey de Grey To make rational choices involves choosing courses of action that best serve one’s ends. As a good example, one’s chances of having a positive impact on the world are significantly greater if one focuses one’s efforts on solving the world’s biggest, most urgent problems than if one focuses one’s efforts on solving comparatively small, non-urgent problems that will not ultimately matter in the long run if the biggest, most urgent problems are left unsolved. Therefore, if one’s goal is to make a difference in the world, then it is simply not rational to focus one’s efforts on solving comparatively small, non-urgent problems. It is true that functioning societies do need people working on comparatively small day- to-day problems.
    [Show full text]
  • Swiss Biotech Report – "Agility, Leadership and Innovation in the Time of COVID-19” – Is Indeed Appropriate
    SwissSwiss BiotechBiotech ReportReport 2021 2019Agility, leadership and innovation in the time of COVID-19 Schweizerische Eidgenossenschaft Confédération suisse Confederazione Svizzera Confederaziun svizra Swiss Confederation Innosuisse – Swiss Innovation Agency “The biopharma industry’s response to COVID-19 has truly been a global one – with Swiss companies and academic institutions at the forefront. Swiss-based biopharma players are contributing across the spectrum of patient needs.” George Scangos | Vir Biotechnology, Inc. “2020 was the best year ever for Swiss biotech in relation to financing activities, with a total of approximately CHF 3.4B raised” Jürg Zürcher | GSA Biotechnology Leader, EY “Compared to 2019, trading volumes rose sharply by 177% and the total free float market capitalization of all SIX-listed biotech companies was up 30% on 2020.” Fabian Gerber | SIX Agility, leadership and innovation in the time of COVID-19 “Technologies developed by scientists in Switzerland have been crucial in the fight against COVID-19, including cloning the virus, cryo electron microscopy to visualize the spike proteins, and the use of radioactive molecules that bind to receptor proteins to investigate how the virus enters the host.” Florian Fisch | Swiss National Science Foundation “On May 1 2020, Moderna and Lonza announced a strategic collaboration to enable manufacturing of up to 1 billion doses of the vaccine per year. Lonza acquired equipment and built the production lines in just 8 months.” Jan Lucht | scienceindustries “Industrial
    [Show full text]
  • 321444 1 En Bookbackmatter 533..564
    Index 1 Abdominal aortic aneurysm, 123 10,000 Year Clock, 126 Abraham, 55, 92, 122 127.0.0.1, 100 Abrahamic religion, 53, 71, 73 Abundance, 483 2 Academy award, 80, 94 2001: A Space Odyssey, 154, 493 Academy of Philadelphia, 30 2004 Vital Progress Summit, 482 Accelerated Math, 385 2008 U.S. Presidential Election, 257 Access point, 306 2011 Egyptian revolution, 35 ACE. See artificial conversational entity 2011 State of the Union Address, 4 Acquired immune deficiency syndrome, 135, 2012 Black Hat security conference, 27 156 2012 U.S. Presidential Election, 257 Acxiom, 244 2014 Lok Sabha election, 256 Adam, 57, 121, 122 2016 Google I/O, 13, 155 Adams, Douglas, 95, 169 2016 State of the Union, 28 Adam Smith Institute, 493 2045 Initiative, 167 ADD. See Attention-Deficit Disorder 24 (TV Series), 66 Ad extension, 230 2M Companies, 118 Ad group, 219 Adiabatic quantum optimization, 170 3 Adichie, Chimamanda Ngozi, 21 3D bioprinting, 152 Adobe, 30 3M Cloud Library, 327 Adonis, 84 Adultery, 85, 89 4 Advanced Research Projects Agency Network, 401K, 57 38 42, 169 Advice to a Young Tradesman, 128 42-line Bible, 169 Adwaita, 131 AdWords campaign, 214 6 Affordable Care Act, 140 68th Street School, 358 Afghan Peace Volunteers, 22 Africa, 20 9 AGI. See Artificial General Intelligence 9/11 terrorist attacks, 69 Aging, 153 Aging disease, 118 A Aging process, 131 Aalborg University, 89 Agora (film), 65 Aaron Diamond AIDS Research Center, 135 Agriculture, 402 AbbVie, 118 Ahmad, Wasil, 66 ABC 20/20, 79 AI. See artificial intelligence © Springer Science+Business Media New York 2016 533 N.
    [Show full text]